Recombinant Human NIS Protein，His & GST

NIS (Sodium/Iodide Symporter) is a crucial membrane protein primarily expressed in thyroid follicular cells, playing a significant role in thyroid hormone synthesis by facilitating iodine uptake. Research into NIS has garnered interest due to its potential implications in both thyroid-related diseases and cancer treatment. In thyroid cancer, for instance, the functionality of NIS can be compromised, leading to reduced iodine uptake which poses challenges for radioiodine therapy. Consequently, understanding the structural and functional aspects of NIS, including its protein folding and trafficking mechanisms, is essential for developing strategies to enhance radioiodine therapy effectivity. Moreover, NIS has garnered attention as a potential therapeutic target in non-thyroid cancers, where it may be exploited for selective delivery of iodine-based therapeutics. Recent advancements in recombinant protein technology enable the production of NIS in sufficient quantities for detailed structural studies, which are critical for elucidating its transport mechanisms and interactions with various ligands. These studies aim to improve our understanding of NIS function and its regulation, facilitating the development of innovative treatments for both thyroid dysfunctions and malignancies. As research evolves, the insights gained from NIS studies promise to enhance the precision of therapies and improve patient outcomes, highlighting the necessity for continued exploration of this vital protein.